Should You Test Crp Twice Per Year?

What Is CRP and Why Does It Matter for Longevity?

C-reactive protein (CRP) is a marker of systemic inflammation produced by the liver in response to injury, infection, or chronic low-grade inflammation. The high-sensitivity version of the test (hs-CRP) is specifically used to assess cardiovascular and metabolic risk — making it one of the more clinically relevant inflammation markers available in standard blood testing.

Chronic low-grade inflammation is increasingly recognised as a driver of biological aging. It contributes to arterial damage, insulin resistance, and accelerated cellular decline — a process sometimes called “inflammaging.” As a result, hs-CRP has become a standard inclusion in longevity-focused blood panels alongside markers like ApoB and HbA1c.

Importantly, hs-CRP is not a diagnostic tool on its own. Elevated levels can reflect a wide range of causes — from poor sleep and excess visceral fat to autoimmune flares or recent illness. That context matters significantly when interpreting results. For a broader look at which markers belong in a longevity panel and why, see our guide to what tests should be in a longevity blood panel.

Should You Test CRP Twice Per Year?

For most individuals with an interest in monitoring inflammation as part of a longevity strategy, testing hs-CRP twice per year is a clinically sensible approach. It provides enough data points to observe meaningful trends over time, while avoiding the noise that comes from testing too frequently.

CRP levels are reactive — they can spike temporarily in response to infection, overtraining, poor sleep, or acute stress. Testing too often means results may reflect short-term disruption rather than your underlying inflammatory status. In contrast, testing just once a year may miss important changes, particularly if you are making lifestyle interventions and want to track their effect.

That said, twice per year is a general pattern rather than a universal rule. The appropriate frequency depends on your health status, risk factors, and what you and your clinician are trying to learn. This is one of several markers worth revisiting on a regular schedule — similar considerations apply to how often you should test ApoB annually and how frequently to track HbA1c.

Learn more in our complete guide to longevity.

When Twice Per Year Makes Sense

Biannual testing is particularly well-suited for people who:

• Have a known cardiovascular risk factor (elevated ApoB, hypertension, family history of heart disease)
• Are managing metabolic conditions such as insulin resistance or type 2 diabetes
• Are actively making lifestyle changes — dietary shifts, new exercise programmes, or weight loss — and want objective feedback
• Have had previously elevated hs-CRP and are monitoring whether it has normalised

In these cases, two data points per year — ideally taken under consistent conditions (fasted, not during illness) — allow for meaningful comparison without over-interpreting minor variation.

When a Different Frequency May Be More Appropriate

For individuals in good health with consistently low hs-CRP and no significant risk factors, annual testing may be entirely sufficient. There is limited clinical value in testing a stable, low marker more often than necessary.

Conversely, more frequent testing — perhaps every three months — may be warranted for people with active autoimmune conditions, recurring inflammatory episodes, or those being monitored following a significant medical event. In these situations, the decision should be driven by a clinician rather than a general protocol.

Factors That Influence Testing Frequency

Underlying Health Conditions and Risk Profile

The strongest argument for more frequent CRP testing is an elevated baseline risk. Individuals with cardiovascular disease, metabolic syndrome, or chronic inflammatory conditions have more to gain from regular monitoring. In these contexts, hs-CRP can help a clinician assess whether inflammation is being adequately managed alongside other interventions.

For generally healthy individuals with low baseline CRP, however, the incremental value of quarterly testing is limited. More data does not always mean better decisions — especially when results are consistently within a healthy range.

Lifestyle Changes and Intervention Tracking

One practical reason to test more frequently — at least temporarily — is to evaluate the impact of a specific intervention. For example, if someone is adopting an anti-inflammatory diet, reducing visceral fat, or beginning a structured exercise programme, testing hs-CRP before and three to six months after can provide objective feedback on whether systemic inflammation is responding.

Once results stabilise, returning to a biannual or annual schedule is reasonable. The goal is not continuous surveillance, but informed tracking at meaningful intervals.

Confounding Factors to Be Aware Of

CRP is sensitive to short-term variables that are unrelated to chronic inflammatory risk. A single elevated result following illness, intense exercise, disrupted sleep, or high stress does not necessarily indicate a chronic problem. For this reason, it is worth ensuring that tests are taken under reasonably stable conditions — and that any unexpected result is confirmed with a follow-up measurement before drawing firm conclusions.

How to Interpret CRP Results in Context

hs-CRP is typically interpreted in ranges:

• Below 1.0 mg/L — Low cardiovascular risk
• 1.0–3.0 mg/L — Intermediate risk; worth monitoring and addressing lifestyle factors
• Above 3.0 mg/L — Elevated risk; warrants clinical attention and investigation of underlying causes
• Above 10 mg/L — Likely reflects acute infection or significant inflammation; should be investigated and retested once resolved

These ranges are reference points, not diagnostic thresholds. A reading of 2.8 mg/L is not categorically different from one of 3.2 mg/L. What matters more is the trend over time, the clinical context, and how this marker relates to others in your panel — including ApoB, HbA1c, blood pressure, and waist circumference.

Elevated hs-CRP alongside high visceral fat, insulin resistance, or poor metabolic markers is a more meaningful signal than an isolated elevation. In that broader context, hs-CRP serves as a useful supporting marker rather than a standalone risk indicator. For context on where CRP sits within a wider longevity testing framework, the Longevity Testing and Trade-Offs hub covers which markers are worth prioritising and how to avoid over-testing.

Frequently Asked Questions

References and Resources

The following sources provide further reading on hs-CRP testing, inflammation, and cardiovascular risk assessment:

Conclusion

For most people monitoring inflammation as part of a longevity or cardiovascular health strategy, testing hs-CRP twice per year is a clinically grounded default. It provides enough information to detect meaningful trends, evaluate the impact of lifestyle changes, and support conversations with a clinician — without the noise that comes from testing too frequently.

That said, frequency should ultimately reflect individual circumstances. Those with elevated baseline risk, active inflammatory conditions, or significant lifestyle changes underway may benefit from more regular testing. In contrast, healthy individuals with consistently low readings may find annual testing entirely sufficient.

The most important principle is that hs-CRP is a supporting marker, not a standalone risk predictor. Its value lies in how it fits alongside other measurements — including ApoB, HbA1c, visceral fat, and blood pressure — as part of a coherent, clinician-guided approach to monitoring long-term health.